Neuralgia Terminated Phase 2 Trials for Fulranumab (DB12102)

Also known as: Neuralgia (finding) / Neuralgia -RETIRED- / Neuralgia NOS / Neuralgia unspecified (disorder)

IndicationStatusPhase
DBCOND0017747 (Neuralgia)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00964990A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)Treatment